Fushan Shi

Dr. Fushan Shi

Auto-generated profile, based on publicly available information

Dr. Fushan Shi


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2019 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YYYang Yang
Yang Yang
HWHuanan Wang
Huanan Wang
MKMohammed Kouadir
Mohammed Kouadir
HSHouhui Song
Houhui Song
FSFushan Shi
Fushan Shi
The NLRP3 inflammasome is a multimeric protein complex that initiates an inflammatory form of cell death and triggers the release of proinflammatory cytokines IL-1β and IL-18. The NLRP3 inflammasome has been implicated in a wide range of diseases, including Alzheimer’s disease, Prion diseases, type 2 diabetes, and some infectious diseases. It has been found that a variety of stimuli including danger-associated molecular patterns (DAMPs, such as silica and uric acid crystals) and pathogen-associated molecular patterns (PAMPs) can activate NLRP3 inflammasome, but the specific regulatory mechanisms of NLRP3 inflammasome activation remain unclear. Understanding the mechanisms of NLRP3 activation will enable the development of its specific inhibitors to treat NLRP3-related diseases. In this review, we summarize current understanding of the regulatory mechanisms of NLRP3 inflammasome activation as well as inhibitors that specifically and directly target NLRP3.

20 November 2019 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
YSYuhua Shi
Yuhua Shi
HWHuanan Wang
Huanan Wang
MZMengjie Zheng
Mengjie Zheng
WXWei Xu
Wei Xu
YYYang Yang
Yang Yang
FSFushan Shi
Fushan Shi
Ginsenoside Rg3 is one of the main constituents of Panax ginseng . Compelling evidence has demonstrated that ginsenoside Rg3 is capable of inhibiting inflammation. However, the mechanism mediating its anti‐inflammatory effects remain unclear. Here we show that ginsenoside Rg3 blocks IL‐1β secretion and caspase‐1 activation through inhibiting LPS priming and the NLRP3 inflammasome activation in human and mouse macrophages. Rg3 specifically inhibits activation of NLRP3 but not the NLRC4 or AIM2 inflammasomes. In addition, Rg3 has no effect on upstream regulation of NLRP3 inflammasome, such as K + efflux, ROS production, or mitochondrial membrane potential. Mechanistically, Rg3 abrogates NEK7‐NLRP3 interaction, and subsequently inhibits NLRP3‐ASC interaction, ASC oligomerization, and speckle formation. More importantly, Rg3 can reduce IL‐1β secretion induced by LPS in mice and protect mice from lethal endotoxic shock. Thus, our findings reveal an anti‐inflammatory mechanism for Rg3 and suggest its potential use in NLRP3‐driven diseases.

3 February 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YSYuhua Shi
Yuhua Shi
YYYang Yang
Yang Yang
WXWeilv Xu
Weilv Xu
DSDongyun Shi
Dongyun Shi
WXWei Xu
Wei Xu
FSFushan Shi
Fushan Shi
Gasdermin D (GSDMD) participates in the activation of inflammasomes and pyroptosis. Meanwhile, ubiquitination strictly regulates inflammatory responses. However, how ubiquitination regulates Gasdermin D activity is not well understood. In this study, we show that pyroptosis triggered by Gasdermin D is regulated through ubiquitination. Specifically, SYVN1, an E3 ubiquitin ligase of gasdermin D, promotes GSDMD-mediated pyroptosis. SYVN1 deficiency inhibits pyroptosis and subsequent LDH release and PI uptake. SYVN1 directly interacts with GSDMD, and mediates K27-linked polyubiquitination of GSDMD on K203 and K204 residues, promoting GSDMD-induced pyroptotic cell death. Thus, our findings revealed the essential role of SYVN1 in GSDMD-mediated pyroptosis. Overall, GSDMD ubiquitination is a potential therapeutic module for inflammatory diseases.

1 March 2021 in International Immunopharmacology
Verified
Journal Article
Closed access
YSYuhua Shi
Yuhua Shi
QLQian Lv
Qian Lv
MZMengjie Zheng
Mengjie Zheng
HSHongxiang Sun
Hongxiang Sun
FSFushan Shi
Fushan Shi

1 September 2017 in International Immunopharmacology
Verified
Journal Article
Closed access
GZGuo Zhu
Guo Zhu
HWHuanan Wang
Huanan Wang
TWTiancheng Wang
Tiancheng Wang
FSFushan Shi
Fushan Shi

9 July 2022 in Phytomedicine
Verified
Journal Article
Closed access
XLXiaodong Li
Xiaodong Li
XWXia Wu
Xia Wu
QWQi Wang
Qi Wang
WXWeilv Xu
Weilv Xu
QZQingwei Zhao
Qingwei Zhao
WLWeifen Li
Weifen Li